Ahead of hearing, FDA questions the efficacy of Capricor’s Duchenne drug
Capricor Therapeutics shares have plunged after FDA staff raised concerns regarding the efficacy and data of its Duchenne heart disease therapy.
4 independently sourced, verified news trends involving Ahead.
This hub is built from stories supported by at least four independent sources and accepted by Newsylist's verification pass. Qualifying coverage spans 4 news categories, from Jun 30, 2026 through Jul 28, 2026.
Open any card for the source list, timeline and coverage-velocity evidence. Raw detections and extractive-only records are excluded from this page.
Capricor Therapeutics shares have plunged after FDA staff raised concerns regarding the efficacy and data of its Duchenne heart disease therapy.
Alabama wide receiver Ryan Coleman-Williams is set to graduate at 19 years old before entering the 2027 NFL Draft.
Beyoncé has surprise-released a new track titled "Morning Dew (Donk)" to coincide with the Fourth of July weekend.
Microsoft's Xbox has withdrawn funding and partnership from IO Interactive's upcoming online fantasy RPG project.